Michael Amoroso - 15 Oct 2022 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
President and CEO, Director
Signature
/s/ Dario Scimeca, Attorney-in-fact for Michael Amoroso
Issuer symbol
DTIL
Transactions as of
15 Oct 2022
Net transactions value
-$14,528
Form type
4
Filing time
18 Oct 2022, 16:13:05 UTC
Previous filing
28 Sep 2022
Next filing
26 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise +24,208 24,208 15 Oct 2022 Direct F1, F2
transaction DTIL Common Stock Sale $14,528 -11,006 -45% $1.32 13,202 17 Oct 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Options Exercise $0 -24,208 -100% $0.000000* 0 15 Oct 2022 Common Stock 24,208 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting and settlement of Restricted Stock Units ("RSUs") on October 15, 2022.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3 The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F4 On October 15, 2021 the Reporting Person was granted RSUs, which vested on October 15, 2022.